147 related articles for article (PubMed ID: 9191875)
1. Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.
Wersäll P; Ohlsson I; Biberfeld P; Collins VP; von Krusenstjerna S; Larsson S; Mellstedt H; Boethius J
Cancer Immunol Immunother; 1997 May; 44(3):157-64. PubMed ID: 9191875
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas.
Faillot T; Magdelénat H; Mady E; Stasiecki P; Fohanno D; Gropp P; Poisson M; Delattre JY
Neurosurgery; 1996 Sep; 39(3):478-83. PubMed ID: 8875477
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
4. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.
Crombet T; Torres O; Rodríguez V; Menéndez A; Stevenson A; Ramos M; Torres F; Figueredo R; Veitía I; Iznaga N; Pérez R; Lage A
Hybridoma; 2001 Apr; 20(2):131-6. PubMed ID: 11394532
[TBL] [Abstract][Full Text] [Related]
6. Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.
Divgi CR; Welt S; Kris M; Real FX; Yeh SD; Gralla R; Merchant B; Schweighart S; Unger M; Larson SM
J Natl Cancer Inst; 1991 Jan; 83(2):97-104. PubMed ID: 1988695
[TBL] [Abstract][Full Text] [Related]
7. Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas.
Stragliotto G; Vega F; Stasiecki P; Gropp P; Poisson M; Delattre JY
Eur J Cancer; 1996 Apr; 32A(4):636-40. PubMed ID: 8695267
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma.
Bier H; Reiffen KA; Haas I; Stasiecki P
Eur Arch Otorhinolaryngol; 1995; 252(7):433-9. PubMed ID: 8562040
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of epidermal growth factor receptor (EGF-R) expression on glioma cells by cytokines].
Adachi K; Herlyn D
Nihon Ika Daigaku Zasshi; 1991 Oct; 58(5):537-46. PubMed ID: 1744226
[TBL] [Abstract][Full Text] [Related]
10. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.
Pellegrini R; Centis F; Martignone S; Mastroianni A; Tagliabue E; Tosi E; Ménard S; Colnaghi MI
Cancer Immunol Immunother; 1991; 34(1):37-42. PubMed ID: 1760809
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
Engebraaten O; Hjortland GO; Juell S; Hirschberg H; Fodstad O
Int J Cancer; 2002 Feb; 97(6):846-52. PubMed ID: 11857366
[TBL] [Abstract][Full Text] [Related]
16. Experimental radioimmunotherapy of a xenografted human glioma using 131I-labeled monoclonal antibody to epidermal growth factor receptor.
Takahashi H; Nakazawa S; Herlyn D
Neurol Med Chir (Tokyo); 1993 Sep; 33(9):610-5. PubMed ID: 7505399
[TBL] [Abstract][Full Text] [Related]
17. Conversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selection.
Chang KH; Kim MS; Hong GW; Shin YN; Kim SH
Exp Mol Med; 2012 Jan; 44(1):52-9. PubMed ID: 22064379
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
[TBL] [Abstract][Full Text] [Related]
19. Induction of a T- and B-cell response against a unique amino acid sequence of the mouse IgG2A hinge region in a MAb-treated patient.
Wersäll P; Fagerberg J; Ohlsson I; Rudén U; Boethius J; Mellstedt H
Int J Cancer; 1997 Dec; 73(6):790-4. PubMed ID: 9399653
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.
Liu X; Dong C; Shi J; Ma T; Jin Z; Jia B; Liu Z; Shen L; Wang F
Oncotarget; 2017 Jan; 8(4):6364-6375. PubMed ID: 28031526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]